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Abstract
Background: Cough is one of the main symptoms of advanced lung disease. However, the efficacy of currently
available treatment remains unsatisfactory. Research into the new antitussives requires an objective assessment of
cough.
Methods: The aim of the study was to test the feasibility of a new automatic portable cough analyser and assess
the correlation between subjective and objective evaluations of cough in 13 patients with chronic cough. The
patients’ individual histories, a cough symptom score and a numeric cough scale (1-10) were used as a subjective
evaluation of cough and a computerized audio-timed recorder was used to measure the frequency of coughing.
Results: The pre-clinical validation has shown that an automated cough analyser is an accurate and reliable tool
for the ambulatory assessment of chronic cough. In the clinical part of the experiment for the daytime, subjective
cough scoring correlated with the number of all cough incidents recorded by the cough analyser (r = 0.63; p =
0.022) and the number of cough incidents per hour (r = 0.60; p = 0.03). However, there was no relation between
cough score and the time spent coughing per hour (r = 0.48; p = 0.1). As assessed for the night-time period, no
correlation was found between subjective cough scoring and the number of incidents per hour (r = 0.29; p = 0.34)
or time spent coughing (r = 0.26; p = 0.4).
Conclusion: An automated cough analyser seems to be a feasible tool for the ambulatory monitoring of cough.
There is a moderate correlation between subjective and objective assessments of cough during the daytime,
whereas the discrepancy in the evaluation of night-time coughing might suggest that subjective analysis is
unreliable.
Background
Cough is one of the main symptoms of advanced lung
disease. However, the efficacy of currently available
treatment remains unsatisfactory. Growing knowledge of
the pathophysiology of cough has resulted in the imple-
mentation of new therapeutic options and research on
future potential treatment modalities [1-3]. Research
into the efficacy of antitussives would, however, require
the objective assessment of cough. Until now the evalua-
tion of the frequency and severity of cough has been
based mainly on patients’ subjective reporting. Accord-
ing to the guidelines of the European Respiratory
Society (ERS) and the American College of Chest Physi-
cians (ACCP), treatment efficacy for chronic respiratory
diseases should be assessed using an objective method
of cough monitoring [4,5]. This very recent recommen-
dation reflects observations from preliminary studies
suggesting a poor and variable relationship between dif-
ferent subjective and objective measures of cough
[6-11]. Despite great progress in the objective evaluation
of cough, the introduction of equipment which would
be useful in everyday clinical practice remains a chal-
lenge. Such portable, low-weight systems should be sim-
ple in their use and application, acceptable to patients
and reliable.
In this study we first tested the feasibility of a new
portable automatic cough analyser (CA) which could be
applied to 24-hour monitoring in an ambulatory setting
(Figure 1). We then used this method to determine the
relation between subjective cough scores and objective
monitoring by a CA. The aim of the clinical part of the
study was to assess the relation between patients’ * Correspondence: damik@amg.gda.pl
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quency and time spent coughing.
Methods
Patients
Sixteen patients who had been treated at the Depart-
ment of Pneumonology and Allergology at the Medical
University of Gdansk, Poland, were included in the
study (Table 1).
The inclusion criteria were as follows: chronic cough
defined according to the ERS [4], being over the age of
18, and giving written informed consent.
The exclusion criterion was asthma exacerbation. The
study was approved by the Local Research Ethics Com-
mittee in Gdansk and patients’ individual histories, a
cough symptom score and a numeric cough scale (1-10)
were used for a subjective evaluation of cough. Portable
cough recording was commenced following lung func-
tion assessment by spirometry. In the case of ambula-
tory patients, these were allowed to go home and
encouraged to wear the cough-recording device for 24
hours. Moreover, they were asked to self-report their
cough during the day and night.
Cough analyser
The cough analyser (CA) designed for the purpose of
the study (MES, Kraków, Poland) was supplied with bat-
teries (2 × AAA 2.4 V) and worn by patients in a special
pouch around the thorax (Figure 1). A microphone with
a reading frequency of 8-1200 Hz was attached to the
pouch and localized in the lower part of the sternum,
approximately 30 cm from the mouth. Signals from a
microphone detector were continuously registered on a
flash memory. After completing the analysis, data were
transferred from the recorder to a personal computer
and read automatically by the software (MES, Kraków,
Poland), allowing for the analysis of particular
parameters.
The CA was able to measure acoustic vibrations con-
tinuously and the signals being transferred to a record-
ing of sound amplitude. The hardware for the CA
allows for a 0.1-second resolution time in registering
signals with a cut-off value of 20 dB, whereas the fre-
quency range is 8-1200 Hz.
Pre-clinical part of the experiment: validation of the MES
CA
The process of the MES CA validation consisted of
three steps.
First - 6 healthy individuals voluntarily produced
cough. A comparison of the agreement of manual
counting by software using the MES Cough Analyser
against counting by the hearing of cough incidents in
real time was checked. The counting error (ECh-m)w a s
assessed according to the following mathematical for-
mula:
(N -N )/N 100% hm m 
Nh - number of incidents counted from hearing in real
time
Nm - number of incidents counted manually by the
software
Table 1 Characteristics of the patients with respiratory diseases included in the study.
Nr Gender
F/M
Age
(years)
Diagnosis Dyspnoea (Borg scale) Spirometry (% of predicted)
FEV1 FVC IN FVC EX FEV1/FVC
1 F 55 Asthma 3 106 104 108 83
2 F 43 Asthma 3 65 76 81 69
3 F 19 Asthma - 105 109 110 83
4 M 34 Asthma 0 76 87 88 71
5 F 36 Asthma 4 101 102 109 79
6 F 58 Asthma 2 37 48 51 61
7 M 48 BHR 2 99 107 110 72
8 F 55 Asthma 5 125 137 143 74
9 F 56 Asthma 5 58 65 72 68
10 F 46 Asthma - 104 104 110 81
11 F 56 Asthma - 106 108 111 81
12 M 53 Asthma 1 96 121 122 62
13 F 48 BHR 2 107 122 127 72
14 F 31 BHR 1 118 122 126 81
15 M 51 Asthma 0 88 113 113 62
16 M 53 BHR 0.5 147 158 155 76
Patients 3, 10 and 11 did not complete the Borg scale; BHR - bronchial hyper-reactivity
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0.37%.
Discrimination afforded by the manual counting of
recordings with software for the MES CA was observed
to be consistent with that achieved by counting in real
time. Thus, the manual counting of the recordings was
assessed as reliable and used in the next steps as the
method of reference for automatic counting.
Second - the calibration of the cough analyser.
Six healthy volunteers coughed in their normal office
environments at work (where external noise such as
talking was present) (Table 2). The counting error (ECa-
m) was evaluated for different parameters of automatic
analysis, such as time (0.1 s or 1 s) and amplitude of
discrimination (5%, 10%, 20% or 40%).
ECa-m was assessed according to the following mathe-
matical formula:
(N -N )/N 100% am m 
Nm - number of incidents counted manually by the
software MES Cough Analyser
Na - number of incidents automatically counted by the
cough analyser
The results of the calibration tests showed that the
optimal parameters of automatic analysis are time dis-
crimination = 1 second and amplitude discrimination =
10%. This means that the recognition of a signal begins
if the amplitude reaches 10% as well as disappearing at
the level of 10%.
Using these parameters of automatic analysis means
that ECa-m was equal to 2.93% (range 2.27-3.57), thus
ECa-m was < 5%.
Third - automatic counting verified against that
achieved via manual counting by the software MES
Cough Analyser during prolonged monitoring (Table 3).
The thirteen measurements in healthy volunteers
lasted a total of 172 hours.
The parameters of digital measurement accepted for
signal detection were based on the results of the pre-
vious step of calibration: discrimination time = 1 second;
minimal amplitude of incident = 10%. Thus, the soft-
ware enabled registration of a 1-second incident as a
cough (minimal cough duration = 1 second). A 1-second
interval was required to discriminate between incidents.
The software presented each incident as a percentage of
the maximum amplitude achieved by an individual
patient. The recognition of a signal began if the
Figure 1 Cough analyser. The cough analyser registered all events continuously and automatically. Patients were handling a device which
allowed them to mark certain important incidents, for example incidental dyspnoea.
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of 10%.
The results of the validation process enabled the cal-
culation of sensitivity greater than 95% (median = 96.8;
range 95.5-98.7), a specificity greater than 99% (median
= 99.6; range 99.5-99.8), and a median false positive rate
= 0.0036 (range 0.0019-0.0054) (Table 3).
Time was measured by the use of a quartz generator
with a frequency of 3.62 MHz and an accuracy and sta-
bility of +/-50 ppm. Thus accuracy of the time measure-
ment is very high, at the level of one-tenth of a
millisecond. The filters of frequency used by us guaran-
teed the time of response < 0.01 second.
The hardware for the CA allows for a 0.1-second reso-
lution time in registering signals. Thus, the hypothetical
error related to the time measurement should be extre-
mely low and acceptable.
Clinical experiment
To eliminate sounds of other than cough origin (i.e.
extraneous noise) during the clinical part, we withdrew
signals with an amplitude lower than 50% of the maxi-
mum amplitude obtained during cough. We quantified
cough in terms of the number of incidents and the time
spent coughing in seconds per hour; we analysed day
and night periods separately.
Subjective measures of cough
Patients were asked to self-assess their cough simulta-
neously with the CA monitoring. The evaluation
included the intensity and duration of the symptom
based on a Numerical Rating Scale (NRS: 1 = no cough
to 10 = worst cough) and a cough scoring system
recommended by the ERS [4,6].
Statistical analysis
The validation of the CA revealed a sensitivity for discri-
minating between coughs equal to 95%. Based on clini-
cal experience, we had assumed the sensitivity of the
cough score to be 55%. We calculated that to obtain a
power of 70% (p = 0.05) for the study we would need a
sample size involving 16 patients [12].
The time for monitoring was arbitrarily divided into
night (N) and day (D) (from 22.00 to 6.00 and the time
remaining, respectively). The steps for the calculation
included: (1) counting the number of cough incidents
during D and N separately; and (2) calculating the mean
number of incidents per hour for D and N. These mean
values were subsequently used for further analysis of
correlations between particular features. The same was
calculated for time spent coughing. Statistical analysis
was conducted using a licensed version of statistical
software: STATISTICA PL 5.0 for Windows. The distri-
bution of variables using the Shapiro-Wilk test was
abnormal, therefore non-parametric statistical tests were
chosen. A Wilcoxon rank test was performed to assess
the differences between particular parameters. Spearman
correlations were used to examine the relationship
between subjective and objective measures of cough.
Results
Sixteen patients with chronic cough were included in
the CA assessment (11 females; median age 49.5 years
[range 19-58]) (Table 1). Among these patients, three
did not finish the subjective assessment. Thus a statisti-
cal assessment of the correlation between the objective
and subjective cough evaluations was conducted for 13
patients (Table 4).
Table 2 The calibration of the cough analyser
Nr Nh Nm Automatic counting by the cough analyser
Td = 0.1s
Ad = 10%
Td = 0.1s
Ad = 20%
Td = 0.1s
Ad = 40%
Td =1s
Ad = 20%
Td =1s
Ad = 10%
Td =1s
Ad =5 %
Na ECa-m
(%)
Na ECa-m
(%)
Na ECa-m
(%)
Na ECa-m
(%)
Na ECa-m
(%)
Na ECa-m
(%)
1 164 162 178 9.88 175 8.03 151 6.79 156 3.7 166 2.47 182 12.35
2 174 177 194 9.61 190 7.35 164 7.35 169 4.52 182 2.83 199 12.43
3 171 173 191 10.41 185 6.94 161 6.94 165 4.62 178 2.89 194 12.14
4 199 197 217 10.15 212 7.61 182 7.61 188 4.57 204 3.55 223 13.20
5 134 132 145 9.85 142 7.58 121 8.33 126 4.55 135 2.27 147 11.36
6 227 224 247 10.27 240 7.14 207 7.59 214 4.46 232 3.57 255 13.84
Nr - number; Nh - number of incidents counted from hearing in real time;
Nm - number of incidents counted manually the software MES Cough Analyser;
Na - number of incidents automatically counted by cough analyser;
ECa-m - counting error; Td - discrimination time; Ad - amplitude of discrimination.
Krajnik et al. BioMedical Engineering OnLine 2010, 9:17
http://www.biomedical-engineering-online.com/content/9/1/17
Page 4 of 9Compatibility
The CA was easy to use and highly acceptable to the
patients, apart from two (patients 12 and 13) who
removed it early due to discomfort during the night.
Eight other patients decided for themselves to shorten
the time of monitoring due to occupational obligations.
Analysis of objective cough monitoring
Among the 16 patients included in the analysis, the med-
ian duration time of objective cough monitoring (the
entire study period) was 21 hours and 45 minutes (range
15-24 hours) (Table 4). The median of cough incidents
for the whole study period was 38.5 per hour, with a wide
range of 0-113. The number of incidents was higher dur-
ing the day than the night-time period. The median num-
ber of incidents per hour during the day was 45.5 (range
0-194); at night this was 8 (range 0-142; p = 0.04, Wil-
coxon rank test). Despite the lack of a significant relation
between the number of cough events per hour during D
and N (r = 0.47; p = 0.063), there was a moderate correla-
tion between the number of all cough incidents during D
and N (r = 0.53; p = 0.034): patients who coughed more
during the day also coughed more at night (Table 5).
The median time spent coughing for the study group
was 16.5 seconds per hour with a wide range between
patients (0-52). Time spent coughing was higher during
the day than at night. The median time spent coughing
during the day was 20 seconds per hour (range 0-78),
whereas at night this was 3 seconds per hour (range 0-
89; p = 0.02, Wilcoxon rank test). There was a moderate
correlation between time spent coughing per hour dur-
ing D and N (r = 0.60; p = 0.015).
Analysis of subjective measurement
Thirteen patients completed the subjective evaluation
form (Table 4). The median cough score during the day
was 3 (range 0-5) and was higher than at night (median
2, range 0-4; p = 0.02; Wilcoxon rank test). There was a
moderate correlation between cough scoring for D and
N (r = 0.77; p = 0.002). Patients with a high cough
score for the day tended to assess night coughing simi-
larly (Table 5).
Correlation between subjective and objective measures
For the daytime, subjective cough scoring correlated
moderately with the number of all cough incidents (r =
0.63; p = 0.022) and the number of cough incidents per
hour (r = 0.60; p = 0.029) (Table 5 and Figure 2). How-
ever, for the daytime period there was no significant
correlation between cough score and the time spent
c o u g h i n gp e rh o u r( r=0 . 4 8 ;p=0 . 1 ) .A sa s s e s s e df o r
the night-time period, there was no significant correla-
tion between subjective cough scoring and all studied
objective parameters, such as the number of incidents
Table 3 The validation of the automatic measurement of cough against manual analysis by the MES Cough Analyser.
Nr T
[h]
Na Nm TP FN FP FP rate TN SENS
[%]
SPEC
[%]
AGREE
[%]
1 8 1282 1238 1198 40 84 0.0035 23672 96.8 99.6 99.5
2 8 1343 1302 1277 25 66 0.0026 25285 98.1 99.7 99.6
3 8 1154 1120 1105 15 49 0.0019 25552 98.7 99.8 99.7
4 8 1705 1648 1620 28 85 0.0036 23692 98.3 99.6 99.5
5 8 1587 1543 1498 45 89 0.0035 25147 97.1 99.6 99.5
6 8 1782 1715 1657 58 125 0.0053 23680 96.6 99.5 99.3
7 16 2184 2114 2048 66 136 0.0027 50722 96.9 99.7 99.6
8 16 2730 2648 2573 75 157 0.0030 51725 97.2 99.7 99.6
9 16 3155 3041 2921 120 234 0.0045 51279 96.0 99.5 99.3
10 16 3286 3159 3024 135 262 0.0053 48928 95.7 99.5 99.2
11 20 3426 3308 3168 140 258 0.0041 62033 95.7 99.6 99.4
12 20 4311 4162 3976 186 335 0.0054 60805 95.5 99.5 99.2
13 20 4139 3984 3850 134 289 0.0046 61451 96.6 99.5 99.3
Nr - number of measurement period; T - duration of measurement in hours; Nm - number of incidents counted manually by software for the MES Cough
Analyser; Na - number of incidents automatically counted by cough analyser; TP - true positives = number of incidents detected by automatic counting and
confirmed by manual analysis; FN - false negatives = number of incidents detected only by manual analysis (not by automatic counting); FP - false positives =
number of incidents detected only by automatic analysis (not by manual counting); TN - true negatives = number of potential incidents not registered by
automatic or manual counting (as the discrimination time was 1 second, a TN was counted as seconds of measurement without incidents registered either by
automatic or manual analysis);
FPrate-falsepositiverate FP/(FP TN); 
SENS-sensitivity TP/(TP FN) 100%; SPEC-specificity TN/(TN     F FP) 100%  ;
AGREE - agreement betweenmanualandautomaticmeasurement (FP     FN)/(TP FP TN FP) 100%. 
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coughing per hour (r = 0.26; p = 0.4). There was no sig-
nificant correlation between the NRS and either cough
incidents per hour (r = 0.52; p = 0.066) or time spent
coughing per hour (r = 0.37; p = 0.21).
Discussion
In the pre-clinical assessment our new portable auto-
matic cough analyser seemed to be a simple and practi-
cal but accurate and reliable method for the objective
prolonged monitoring of cough in an ambulatory set-
ting. Our pilot clinical studyc o m p a r e ds u b j e c t i v ea n d
objective evaluations of cough in patients with chronic
cough. The results showed a moderate correlation
between cough scoring and the number of cough inci-
dents measured with the CA during the day, whereas
there was a lack of correlation between these parameters
at night.
Until now the relationships between different subjec-
tive and objective measures of cough have not been
Table 4 Objective and subjective parameters of cough
Nr Study duration
(h)
Time spent coughing per hour Number of incidents per hour Longest interval between
incidents (min)
Cough scoring NRS
1-10
Total
(sec)
Day
(sec)
Night
(sec)
Total Day Night Day Night
1 24 17 12 27 63 31 128 85 5 4 7
2 24 47 67 7 51 70 13 88 4 3 4
3 17.5 20 30 9 56 72 38 277 - - -
4 24 40 16 89 61 21 142 112 3 0 4
5 24 12 15 7 37 44 25 168 4 2 6
6 22.5 1 1 0 2 3 0 622 1 0 3
7 20 18 28 4 40 59 11 95 3 1 4
8 20.5 5 9 0 13 22 1 284 4 3 5
9 24 34 51 2 71 104 4 153 5 3 9
10 21.5 49 75 4 105 160 12 117 - - -
11 15 52 78 29 113 194 41 60 - - -
12 22 8 12 2 16 22 5 129 0 2 1
13 19 15 24 2 29 47 4 101 3 2 7
14 23.5 4 7 0 3 4 0 601 3 2 5
15 17 0 0 0 0 0 0 - 0 0 1
16 20 16 26 1 33 53 2 95 3 0 8
Cough scoring recommended by the ERS [6]. Cough scoring during daytime: 0 = no cough during the day; 1 = cough for one short period; 2 = cough for more
than two short periods; 3 = frequent coughing, which did not interfere with usual daytime activities; 4 = frequent coughing, which did interfere with usual
daytime activities; 5 = distressing coughs most of the day. Cough scoring during night-time: 0 = no cough during the night; 1 = cough on waking only; 2 =
waking once or early due to cough; 3 = frequent waking due to cough activities; 4 = frequent coughs most of the night; 5 = distressing coughs preventing any
sleep.
Table 5 Correlation between different parameters of cough
Spearman correlation
Number of coughs per hour Time spent coughing per hour (sec/
h)
Cough score for a
night period
Total Day Night Total Day Night
Number of incidents per hour during
daytime
0.47
(p = 0.064)
Time spent coughing per hour (sec/h)
during daytime
0.60
(p = 0.014)
Cough intensity by the NRS 0.52
(p = 0.066)
0.37
(p = 0.21)
Cough score for a day period 0.60
(p = 0.029)
0.48
(p = 0.1)
0.77 (p = 0.002)
Cough score for a night period 0.29
(p = 0.34)
0.26 (p = 0.4)
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[9-11]. In children with recurrent cough, 24-hour cough
counts correlated moderately with cough scores assessed
through the use of a colour-coded chart and a Visual
Analogue Scale [7]. When the observation period was
divided into day- and night-time, subjective night-time
reporting of cough by children was unreliable [13-17].
Therefore, some authors have suggested that night-time
cough should be removed from children’s symptom dia-
ries [16,18]. In adult patients with chronic obstructive
pulmonary disease, subjective measures of cough corre-
late moderately with time spent coughing both during
the day and at night [19]. By contrast, in patients with
asthma or chronic dry cough subjective reporting
Figure 2 Correlation between subjective cough scoring and the number of cough incidents per hour assessed for one daytime period
(r = 0.60; p = 0.029).
Figure 3 Correlation between subjective cough scoring and the number of cough incidents per hour assessed for one night-time
period (r = 0.29; p = 0.34).
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chronic dry cough and only during the day [6]. In the
present study, we demonstrate a moderate correlation
between subjective cough scoring and the number of
cough incidents per hour measured with a CA for the
daytime. However, no such correlation was found for
the night-time period. Thus, despite the main limitation
of our study due to the small sample size, our results
support the observation that nocturnal cough might be
unreliably reported in adults. An explanation for this
phenomenon is difficult. Cough has been shown to be
significantly influenced by the psychological status of
t h es u b j e c t s[ 2 0 , 2 1 ] .W em i g h th y p o t h e s i z et h a tt h e
negative impact on quality of life from night cough is
significant and leads to an overestimation of its severity.
The other possible explanation is that patients transfer
their daytime evaluation to the night-time assessment.
Moreover, they might poorly and subjectively rate cough
as a symptom both by day and night.
Recently, the need for integrated recording systems for
cough assessment has been stressed, particularly in the
clinical evaluation of drug efficacy [4,5]. There is still a
need to differentiate between cough and non-cough sound
[13,22-25]. In our study, the localization of the low-volume
unidirectional contact microphone helped to eliminate
extraneous noise and increase the chance that only high-
amplitude sounds occurring close to the microphone
would be detected. Our pilot study is an attempt to find
the optimal means of reliable chronic cough assessment
by using a practical and simple method.
It is worth mentioning that a group from Leicester,
UK, introduced an automated system for the 24-hour
monitoring of cough frequency. Their studies have
proved to be significant, with repeatable differences seen
in cough frequency between patients with chronic
cough and healthy controls [26]; they have further vali-
dated their system against manual counts obtained by a
trained observer [27]. Thus, they confirm that the auto-
mated counting of cough events is a reliable and objec-
tive method.
However, it is likely that automated cough monitoring
is both device and method specific; therefore, the find-
ings of previous studies cannot be extrapolated to new
devices.
The unsatisfactory effectiveness of currently available
antitussives, particularly in patients with advanced lung
disease, has provoked increased interest in the develop-
ment of some novel approaches. One of these is to
reach opioid receptors in the trachea-bronchial tract
using nebulised opioids [28] or other targets involved in
cough, including transient receptor potential vanilloid-1
antagonists, selective cannabinoid agonists, maxi-K
channel openers and purinergic receptor antagonists
[for a review of this see [29]].
Clinical trials on new antitussive drugs would require
the thorough objective assessment of the intensity and
frequency of cough, which means that introducing por-
table devices such as a CA might be of clinical
relevance.
Conclusions
We conclude that appropriate night-time cough evalua-
tion requires both subjective and objective monitoring.
T h es e v e r i t yo fc o u g hd e f i n e db yap a t i e n tm a yn o t
represent its frequency and duration when measured
objectively. The use of ambulatory cough analysers
should not be limited to research but might be helpful
in clinical practice, particularly when symptomatic treat-
ment is the main or only purpose of the approach.
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